Literature DB >> 11856798

Strategies to improve long-term outcomes after renal transplantation.

Manuel Pascual1, Tom Theruvath, Tatsuo Kawai, Nina Tolkoff-Rubin, A Benedict Cosimi.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11856798     DOI: 10.1056/NEJMra011295

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  146 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.

Authors:  J D Scandling; S Busque; S Dejbakhsh-Jones; C Benike; M Sarwal; M T Millan; J A Shizuru; R Lowsky; E G Engleman; S Strober
Journal:  Am J Transplant       Date:  2012-03-08       Impact factor: 8.086

Review 3.  Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Authors:  Renaud Snanoudj; Julien Zuber; Christophe Legendre
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

4.  Gazing into a crystal ball to predict kidney transplant outcome.

Authors:  Bernd Schröppel; Peter S Heeger
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 5.  Antiviral treatment for chronic hepatitis B in renal transplant patients.

Authors:  Ezequiel Ridruejo
Journal:  World J Hepatol       Date:  2015-02-27

Review 6.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Authors:  Angela C Webster; Rebecca C Woodroffe; Rod S Taylor; Jeremy R Chapman; Jonathan C Craig
Journal:  BMJ       Date:  2005-09-12

Review 7.  Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability?

Authors:  Oriol Bestard; Josep M Cruzado; Josep M Grinyó
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 8.  [Modern immunosuppression following renal transplantation. Standard or tailor made?].

Authors:  K Budde; M Giessing; L Liefeldt; H-H Neumayer; P Glander
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

9.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

10.  Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy.

Authors:  Baowei Peng; Peiqing Ye; David J Rawlings; Hans D Ochs; Carol H Miao
Journal:  Blood       Date:  2009-09-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.